Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trialarticle Published on 2024-01-182024-09-05 Journal: Journal of hypertension [Category] update2024, [키워드] adherence antihypertensive drugs hypertension Intervention Therapeutic Drug Monitoring [DOI] 10.1097/HJH.0000000000003585 PMC 바로가기 [Article Type] article
Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC–MS/MS profiling of potential impurities: greenness and whiteness evaluationarticle Published on 2023-08-192024-09-05 Journal: BMC Chemistry [Category] update2024, [키워드] antihypertensive drugs Diverse pharmaceutical combinations Greenness and whiteness evaluation HPLC–DAD impurity profiling LC–MS/MS [DOI] 10.1186/s13065-023-01015-z PMC 바로가기 [Article Type] article
Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studiesarticle Published on 2023-05-272024-09-05 Journal: BMC Med Res Methodol [Category] update2024, [키워드] CHRIS study aldosterone angiotensin antihypertensive drugs cluster analysis Lasso regression [DOI] 10.1186/s12874-023-01930-8 PMC 바로가기 [Article Type] article
Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19Article Published on 2022-09-012023-07-09 Journal: Respirology (Carlton, Vic.) [Category] COVID19(2023년), [키워드] antihypertensive drugs COVID-19 hypertension renin-angiotensin-system inhibitors (RASi). SARS-CoV-2 [DOI] 10.1111/resp.14306 PMC 바로가기
A retrospective analysis of incidence and severity of COVID-19 among hypertensive patients: the other sideObservational Study Published on 2022-07-042023-07-09 Journal: Clinical and experimental hypertension (New York, N.Y. : 1993) [Category] COVID19(2023년), [키워드] antihypertensive drugs Arterial hypertension COVID-19 Prognosis SARS-CoV-2 [DOI] 10.1080/10641963.2022.2071916 [Article Type] Observational Study
Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases심장 보호 약물과 COVID-19 치료에 사용되는 약물 간의 약물 상호 작용 위험: 6개 데이터베이스의 증거 기반 검토Review Published on 2022-03-012022-09-11 Journal: Diabetes & metabolic syndrome [Category] SARS, 변종, 신약개발, 치료법, 치료제, [키워드] acting antihypertensive drugs approved Atazanavir Azithromycin cardiovascular system caution Chloroquine close monitoring comorbid condition comorbid conditions Comorbidity concomitant use COVID COVID- 19 treatment COVID-19 COVID-19 infection COVID-19 treatment database Dexamethasone diabetes dosage drug drug interaction drug-drug interaction drugs Effect Effects ENhance Evidence Factor FDA glycemic control group hypertension Hypotension Improving Infection information Interaction interaction effect life Lopinavir Lopinavir/ritonavir Medicine Medscape molnupiravir monoclonal antibodies monoclonal antibody Nirmatrelvir Patient Paxlovid polypharmacy Potential Quality of life Remdesivir resulting review risk Ritonavir therapeutic efficacy therapy treating COVID-19 Treatment worsening [DOI] 10.1016/j.dsx.2022.102451 PMC 바로가기 [Article Type] Review
The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic MiceOriginal Article Published on 2022-01-012022-10-29 Journal: Journal of Cardiovascular Translational Research [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] ACE2 ACE2 expression acute respiratory syndrome angiotensin converting enzyme 2 antihypertensive drugs AT1 AT1 receptor blocker AT1R ATIR Biomarker blocker cellular entry coronavirus Coronavirus disease 2019 COVID-19 COVID-19 patient CRP determine Effect enzyme hACE2 had no Heart injury higher risk hospitalized COVID-19 patient hypertension hypertensive hypertensive COVID-19 patient hypertensive patient IL-1 IL-6 inflammation marker Inpatient kidney outcome Post-infection receptor renin-angiotensin system required SARS-CoV-2 SARS-COV-2 infection serum severity supplementary material transgenic mice treated Treatment [DOI] 10.1007/s12265-021-10147-3 PMC 바로가기 [Article Type] Original Article
Data mining methodology for response to hypertension symptomology—application to COVID-19-related pharmacovigilance고혈압 증상에 대한 데이터 마이닝 방법론 - COVID-19 관련 약물 감시에 적용Research Article Published on 2021-11-232022-09-10 Journal: eLife [Category] MERS, SARS, 치료기술, [키워드] acting acute respiratory illness ADE ADEs Adverse Affect affecting angiotensin Antihypertensive drug antihypertensive drugs Antithrombotic artificial intelligence association beraprost blockers blood pressure bosentan build calcium calcium channel calcium channel blockers candesartan Cluster Combination confounding factor confounding factors coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-related pharmacovigilance data-driven methodology demographics disease Disease prevalence distribution doxazosin drug drugs effective endothelin receptor antagonist Endothelin receptor antagonists Epoprostenol evaluated exhibited Factor FDA FDA ADE database feature filtered Friedman test funding geometric geometric mean group had no hidden high risk highest hypertension Hypothesis incidence limit macitentan medication medications meta-analyses Meta-analysis methodology monotherapy Nifedipine None operator outcome Patient patients pharmacovigilance Potential potential therapy profile Pulmonary function pulmonary symptomology Quantitative randomized clinical trials Renin renin-angiotensin system reported Reporting respiratory Respiratory illness retrieved rilmenidine selected drug selected drugs selexipag shown Side effect significant difference significant differences significantly higher Sildenafil Stage Tadalafil Therapeutics therapy [DOI] 10.7554/eLife.70734 PMC 바로가기 [Article Type] Research Article
Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysisMeta-Analysis Published on 2021-05-012023-07-12 Journal: Journal of cardiology [Category] SARS, [키워드] antihypertensive drugs COVID-19 Meta-analysis SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 [DOI] 10.1016/j.jjcc.2020.10.015 PMC 바로가기 [Article Type] Meta-Analysis
Drug-utilisation profiles and COVID-19Article Published on 2021-04-262022-10-29 Journal: Scientific Reports [Category] COVID-19, MERS, SARS, [키워드] acting age and sex antihypertensive drugs association ATC B01 Campania carried category Characteristics Chemical collected Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient database drug Effect Epidemiology generate Health policy healthcare Healthcare system highlight hypothese individual Infectious diseases information Italy medication monotherapy Mortality non-COVID-19 patient Outcomes research positive Prevalence prevalence rate profile profiles renin-angiotensin system retrospective study cohort susceptibility tested to define [DOI] 10.1038/s41598-021-88398-y PMC 바로가기 [Article Type] Article